Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials.

Conclusions: Up to 2 years of CE 0.45 or 0.625 mg with BZA 20 mg had an acceptable cardiovascular safety profile, with rates of stroke and CHD comparable to placebo in healthy postmenopausal women. VTE risk was low. PMID: 25511453 [PubMed - as supplied by publisher]
Source: Climacteric - Category: Geriatrics Authors: Tags: Climacteric Source Type: research